Literature DB >> 25394258

Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013.

C Chatt1, R Gajraj, J Hawker, K Neal, M Tahir, M Lawrence, S J Gray, J Lucidarme, A D Carr, S A Clark, T Fowler.   

Abstract

Molecular PorA subtyping provides information that increasingly requires the adaptation of standard public health approaches to outbreak management. We report an outbreak of a rare subtype of meningococcal infection not previously identified in the United Kingdom (UK). The outbreak occurred in the Warwickshire area in England between February and June 2013. Molecular subtyping allowed the identification of additional cases, prompting an enhanced public health response that included efforts to identify potential social networks that might benefit from chemoprophylaxis. It also prompted swabbing to define nasopharyngeal carriage in the focal nursery and helped explain the unusual epidemiological pattern. Without subtyping to identify a link, the additional cases would have been managed as sporadic cases in accordance with current UK guidance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394258     DOI: 10.2807/1560-7917.es2014.19.44.20949

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  7 in total

1.  A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone.

Authors:  L Valinsky; J Jaffe; N Keller; C Block; N Abramson; C Stein-Zamir
Journal:  Epidemiol Infect       Date:  2015-06-26       Impact factor: 4.434

2.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

3.  Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015.

Authors:  Jonathan Lawler; Jay Lucidarme; Sydel Parikh; Lorna Smith; Helen Campbell; Ray Borrow; Steve Gray; Kirsty Foster; Shamez Ladhani
Journal:  Euro Surveill       Date:  2019-06

4.  Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).

Authors:  Shamez N Ladhani; Helen Campbell; Jay Lucidarme; Steve Gray; Sydel Parikh; Laura Willerton; Stephen A Clark; Aiswarya Lekshmi; Andrew Walker; Sima Patel; Xilian Bai; Mary Ramsay; Ray Borrow
Journal:  BMC Infect Dis       Date:  2019-06-14       Impact factor: 3.090

5.  Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B in a nursery school, Wallonia, Belgium, 2018.

Authors:  Stéphanie Jacquinet; Wesley Mattheus; Sophie Quoilin; Chloé Wyndham-Thomas; Charlotte Martin; Dimitri Van der Linden; André Mulder; Julie Frère; Carole Schirvel
Journal:  Euro Surveill       Date:  2022-03

6.  Resolution of a Protracted Serogroup B Meningococcal Outbreak with Whole-Genome Sequencing Shows Interspecies Genetic Transfer.

Authors:  Robert M Mulhall; Carina Brehony; Lois O'Connor; Kenneth Meyler; Keith A Jolley; James Bray; Desiree Bennett; Martin C J Maiden; Robert Cunney
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

Review 7.  Meningococcal serogroup B vaccines: Estimating breadth of coverage.

Authors:  Robert G K Donald; Julio Cesar Hawkins; Li Hao; Paul Liberator; Thomas R Jones; Shannon L Harris; John L Perez; Joseph J Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.